Results 11 to 20 of about 232,421 (202)

Mother-to-child transmission of HIV-1 and infant mortality in the first six months of life, in the era of Option B Plus combination antiretroviral therapy

open access: yesInternational Journal of Infectious Diseases, 2021
Objectives: The aim of this study was to determine the contributions of intrauterine (IU), intrapartum (IP), and postpartum (PP) transmission to mother-to-child transmission of HIV-1 (MTCT) and infant mortality in the first 6 months of life, in the era ...
Lynn S. Zijenah   +4 more
doaj   +3 more sources

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis

open access: yesFrontiers in Immunology, 2021
BackgroundAtezolizumab plus chemotherapy has been recommended as a first-line treatment option for patients with advanced non-small cell lung carcinoma (NSCLC) irrespective of programmed cell death-ligand 1 (PD-L1) expression.
Dan-Ni Li   +29 more
doaj   +1 more source

Cessation of breastfeeding and associated factors in the era of elimination of mother to child transmission of HIV at Ndejje health center, Uganda: a retrospective cohort study

open access: yesInternational Breastfeeding Journal, 2020
Background Breastfeeding an infant exposed to Human Immunodeficiency Virus (HIV) carries the risk of HIV acquisition whilst not breastfeeding poses a higher risk of death from malnutrition, diarrhea, and pneumonia.
Jackslina Gaaniri Ngbapai   +2 more
doaj   +1 more source

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore. [PDF]

open access: yesPLoS ONE, 2011
OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available.
Tze-Peng Lim   +6 more
doaj   +1 more source

Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change

open access: yesSwiss Medical Weekly, 2013
Guidelines on prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) are inconsistently implemented in low-income countries.
Anna Gamell   +7 more
doaj   +1 more source

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors

open access: yesCurrent Oncology, 2021
In B-chronic lymphocytic leukemia (B-CLL), the interaction between leukemic cells and the microenvironment promotes tumor cell survival. The Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib is one of the first-in-class molecules for the treatment of B ...
Erika Rimondi   +10 more
doaj   +1 more source

The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial

open access: yesFrontiers in Immunology, 2023
PurposeThis multicenter, open-label, phase Ib/II study aimed to assess the efficacy and safety of cadonilimab, a humanized, tetravalent, bispecific antibody plus lenvatinib in first-line treatment of advanced hepatocellular carcinoma (aHCC ...
Qian Qiao   +19 more
doaj   +1 more source

Sublingual Misoprostol Versus Local Misoprostol With Foleys Catheter Cervical Insertion in Management of Missed Abortion [PDF]

open access: yesZagazig University Medical Journal
Background: Misoprostol is a successful abortion medication when administered vaginally, orally, or sublingually. we aimed for comparing safety in addition to efficacy of different regimens for missed abortion termination of through using sublingual ...
Hoda Sibai   +3 more
doaj   +1 more source

Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study

open access: yesScientific Reports, 2022
The glucagon-like peptide-1 receptor agonist family together with the renal sodium/glucose cotransporter-2 inhibitors have garnered interest as potential therapeutic agents for subjects with type 2 diabetes and obesity.
Carolina López-Cano   +6 more
doaj   +1 more source

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI

open access: yesFrontiers in Oncology, 2021
PurposePlatinum-based chemotherapy remains the classic treatment option for patients with advanced non-small-cell lung cancer (NSCLC) who progress while receiving treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs).
Haiyi Deng   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy